What explains our lower back pain? Anthropologists turn to Neandertals for answers

Spinal curvatures


Contributions to curvature of the modern human spine. Wedging of the vertebral bodies and intervertebral discs results in thoracic kypohsis and lumbar lordosis. Image courtesy of Scott Williams, NYU’s Department of Anthropology.

Examining the spines of Neandertals, an extinct human relative, may explain back-related ailments experienced by humans today, a team of anthropologists has concluded in a new comparative study. 

The analysis centers on the spine’s curvature, which is caused, in part, by a wedging, or angling, of vertebrae and the intervertebral discs—the softer material between the vertebrae.

“Neandertals are not distinct from modern humans in lumbar wedging and therefore likely possessed curved lower backs like we do,” explains Scott Williams, an associate professor in New York University’s Department of Anthropology and one of the authors of the paper, which appears in the journal PNAS Nexus. “However, over time, specifically after the onset of industrialization in the late 19th century, we see increased wedging in the lower back bones of today’s humans—a change that may relate to higher instances of back pain, and other afflictions, in postindustrial societies.”

An image and caption of the human spine, which illustrates how wedging contributes to its curvature, may be downloaded from Google Drive.

Neandertals have long been thought to have a different posture than modern humans. 

“A good part of this perspective derives from the wedging of Neandertals’ lumbar, or lower, vertebrae—their spines in this region curve less than those of modern humans studied in the U.S. or Europe,” explains Williams. 

However, much of this view was based on an analysis of modern humans beginning in the late 19th century—well after the onset of industrialization, which significantly altered our daily lives. Furniture, for instance, became more widely available and desk jobs more prevalent—both of which encouraged sitting and, with it, changes in posture. These changes were coupled with a reduction in high-activity occupations, such as agriculture. In addition, specific afflictions became associated with working conditions that elicit poor posture.

“Past research has shown that higher rates of low back pain are associated with urban areas and especially in ‘enclosed workshop’ settings where employees maintain tedious and painful work postures, such as constantly sitting on stools in a forward leaning position,” Williams observes.

In other words, by examining spines from humans who lived in the post-industrial era, past researchers may have mistakenly concluded that spine formation is due to evolutionary development rather than changed living and working conditions. 

To address this possibility, Williams and his colleagues examined both pre-industrial and post-industrial spines of male and female modern humans from around the world—a sample that included more than 300 spines, totaling more than 1,600 vertebrae—along with samples of Neandertal spines.

Overall, they found that spines in post-industrial people showed more lumbar wedging than did those in pre-industrial people. Moreover, Neandertals’ spines were significantly different from those in post-industrial people but not from pre-industrial people. Notably, the scientists found no differences linked to geography within samples from the same era. 

“A pre-industrial vs. post-industrial lifestyle is the important factor,” explains Williams, who acknowledges that because lower back curvature is made up of soft tissues (i.e., intervertebral discs), not just bones, it cannot be ascertained that Neandertals’ lumbar lordosis differed from modern humans.

“The bones are often all that is preserved in fossils, so it’s all we have to work with,” he adds.

Nonetheless, the distinctions in spine formation between pre-industrial and post-industrial humans offer new insights into back conditions facing many today.

“Diminished physical activity levels, bad posture, and the use of furniture, among other changes in lifestyle that accompanied industrialization, resulted, over time, in inadequate soft tissue structures to support lumbar lordosis during development,” Williams says. “To compensate, our lower-back bones have taken on more wedging than our pre-industrial and Neandertal predecessors, potentially contributing to the frequency of lower back pain we find in post-industrial societies.” 

The study also included researchers from the University of Johannesburg, Texas A&M University, the New York Institute of Technology, Arizona State University, and Chaffey College, along with Monica Alivez, an NYU doctoral student, and Saul Shukman, an NYU undergraduate student.

Chronic neuropathic, ‘phantom’ pain comes from affected nerve and spinal cord, not brain

Neurons and nerve pain
Neurons and nerve pain

By some accounts, chronic pain affects nearly 100 million Americans from such varied causes as arthritis, sciatica, cancer, diabetes. Most forms of pain result from identifiable causes which serve the “good” purpose in warning of a real physical problem that needs attention, or rest.

Another kind of chronic pain may start with a specific injury, surgery or disease event, but may linger for weeks or even years beyond any useful protective function. Such events range from shingles to open-heart surgery where up to half the patients suffer long-term pain, breast removal (sometimes even lumpectomies), or – in the most drastic cases, spinal injury or amputation.

Such “neuropathic pain” is particularly vexing and difficult to treat because there’s no agreed location or physiological mechanism to target for therapy. New research from the University of Alberta, Canada appearing in the Journal of Neurophysiology reported that the place to look is between the nerves that are producing the pain and the spine, rather than from the spine to the brain, according to the senior author, Peter A. Smith.

The paper, “Sciatic chronic constriction injury produces cell-type specific changes in the electrophysiological properties of rat substantia gelatinosa neurons,” is in the online Journal of Neurophysiology, published by The American Physiological Society. Research was by Sridhar Balasubramanyan, Patrick L. Stemkowski, Martin J. Stebbing and Peter A. Smith, University of Alberta, Canada; Stebbing is also at RMIT University, Bundoora, Australia.

Importance of identifying peripheral nerves as key target

Marshall Devor, a professor at the Institute of Life Sciences, and at the Center for Research on Pain, Hebrew University, Jerusalem, said “the results reported in this paper are quite optimistic in terms of the prospects for finding future methods of treatment. First,” he said, “because if the problem is in the spine or the brain, it’s hard to treat. But if the impact is in the nerve, we have a better idea where to look and it’s also easier to target therapy there.”

Devor added that the Alberta team “didn’t prove that the central nervous system isn’t involved, but they have shown that the peripheral nerve probably is highly involved.” Devor wrote an editorial in the Journal accompanying the Balasubramanyan et al. paper.

Paradoxes abound: role of inflammation, contrary reactions; Iraq casualties

“The subject gets complicated quickly and is full of paradoxes,” Smith said: “For instance, in chronic pain there’s often an emotional element. If a patient has post-traumatic stress syndrome, that could make the pain worse because there are overlapping disorders.”

The war in Iraq has highlighted the issue of chronic neuropathic pain in amputations (called “phantom limb pain”) because the rate of amputations is so high compared to previous wars.

Smith said that another “big issue in chronic pain is that two people can have more or less identical injuries, and one gets chronic pain, but the other doesn’t. It may have to do with the immune system and inflammation,” he said.

Another paradox, he pointed out, is that “most types of pain are associated with tissue damage and inflammation. Because neuropathic pain can go on for years after initial inflammation has subsided, it is defined as ‘noninflammatory pain.’ Although this definition is accurate, it may have clouded our thinking as to how neuropathic pain is initiated. Current research suggests that an initial transient inflammatory event may set the whole long term pain sequence into motion,” he said.

Classic explanation found lacking, though spinal changes identified

In the current study, researchers constricted the sciatic nerve of young rats, then studied what changes had occurred in the substantia gelatinosa. This translucent area of the spinal cord is involved in the processing of unpleasant sensations that can be perceived as painful. According to Devor, much has been made of the theory that neuropathic pain actually “imprints” changes in the spinal column that are responsible for the long-lived chronic pain.

What Balasubramanyan et al. found, however, didn’t quite match what they, or others, might have expected. According to their discussion section: “Given the increase in the excitability of dorsal horn neurons that follows peripheral nerve injury in vivo, and the presence of mechanical hypersensitivity (heightened pain responses) in our experimental animals, the observed changes in the properties of substantia gelatinosa neurons at first seem relatively modest.” For example, CCI [chronic constriction injury] did not promote the generation of spontaneous action potentials in substantia gelatinosa neurons.

They conclude that CCI indeed produced a certain level of bona fide “centralization” in that it “alters the intrinsic properties of the dorsal horn by exerting both pre- and postsynaptic effects on excitatory synaptic transmission and by attenuating inhibitory transmission.” However, the “relative contribution of intrinsic, peripheral and descending mechanisms to nerve injury-induced ‘central hypersensitivity’ is yet to be determined.”

New directions in treating pain

In addition to further studies designed to identify more precisely what changes occur in neuropathic and chronic pain scenarios, Smith said there is still much to be done in determining how to treat such pain, whatever the mechanisms.

For instance, it may be most appropriate to target the initial injury that precipitates the enduring neuropathic pain. In fact, this is already done by the use of pre-emptive anesthesia during surgery. The surgeon uses a local anesthetic to deaden the nerves as well as a general anesthetic to immobilize the patent for surgery. Such procedures should be encouraged, Smith said. Another possibility may be to suppress the immune system for the initial five days after injury. This may curtail the inflammation associated with peripheral nerves that appears to trigger many aspects of neuropathic pain.

  • According to lead author Sridhar Balasubramanyan: “Clearly, what needs to be done now is to go back to the periphery and concentrate on finding what physiological mechanisms might be at work closer to the removed part or the original injury site, as in cases of diabetic neuropathy, shingles and surgery.”
  • The whole issue of treating chronic and neuropathic pain continues to mystify clinicians and researchers, Smith noted. For instance “opiates work well in almost all cases of regular pain, but morphine is of limited use in chronic pain.”

A recent article in Psychiatric Times by Steven A. King reported that while the “apparent neuropathic nature of phantom limb pain (PLP) would suggest that antidepressants, anticonvulsants and similar medications would be most efficacious…most (PLP) patients are treated with acetaminophen, nonsteroidal antiinflammatories and opioids.” A survey article by M.A. Hanley and associates found that just over half of PLP patients, and over one-third of severe PLSP patients, “had never been treated” at all for their pain.

Experience of arm pain needed to help shape new research

Alarming numbers of doctors experiencing mental health issues as a result of work pressures
Alarming numbers of doctors experiencing mental health issues as a result of work pressures

People living with painful hand and arm conditions are invited to take part in research and help create a new online support platform for patients. 

The research is open to people with a range of complaints including hand and thumb osteoarthritis, tendonitis, tennis and golfers’ elbow, carpal tunnel syndrome and non-specific arm pain – previously termed repetitive strain injury. 

Musculoskeletal diseases such as these conditions affect an estimated 10 million people across the UK, causing more disability than either heart disease or cancer. 

Researchers at the University of Leeds’ Faculty of Medicine and Health, Keele University’s School of Medicine and Impact Accelerator Unit, University of Southampton and the University of Aberdeen will work in collaboration with people living with these conditions to design, develop and test a new online programme. It will feature support, information, and a tailored, progressive exercise plan, to guide people in managing their condition.

Lead researcher Philip Conaghan, Professor of Musculoskeletal Medicine in the University of Leeds’s Institute of Rheumatic and Musculoskeletal Medicine, said: “Musculoskeletal diseases are common, chronic and disabling. Not only do they affect people physically, causing significant pain and disability, they also have a major impact on mental health and well-being. The symptoms and wider-reaching consequences can also impact upon people’s ability to function in their work, family and social lives. 

“There are currently few treatment options, with little evidence for long-term benefit. The best approach to managing these conditions, therefore, remains uncertain.

“The design of our new resource will be guided by expertise through lived experience, ensuring that the diverse supportive needs of people living with this range of conditions are met.” 

The six-year research project, titled Digital – My Arm Pain Programme (D-MAPP), is funded by the National Institute for Health Research (NIHR), the research partner of the NHS, public health and social care, and the charity Versus Arthritis. 

Dr Neha Issar Brown, Director of Research at Versus Arthritis, said: “Pain is complex and impacts every aspect of your life. People with musculoskeletal (MSK) conditions like arthritis often need more than just medication. They need support with mental health, sleep, mobility, exercise, self-management tools and much more. However, finding the right information and support you need can be difficult.  

“Being guided by the lived experience of people with MSK conditions means the platform will be much better placed in enabling people to manage their pain in a way that works for them, by giving access to expert advice and support from the comfort of home.” 

Both people with a musculoskeletal condition of the hand or arm, and healthcare professionals with experience in treating these conditions, are invited to take part in co-creating and testing the D-MAPP website. 

They will be invited to take part in a survey study, small group discussions and interviews. They can then support the researchers to design the final online programme, which will be tested out on a larger scale. 

Further information, and an initial questionnaire, is available online or by contacting the research team at D-MAPP@leeds.ac.uk. Much of the research will take place online so participants do not need to travel. 

Further information 

Contact University of Leeds press officer Lauren Ballinger via l.ballinger@leeds.ac.uk with media enquiries. 

Telephone-based therapy and exercise appear effective for reducing chronic widespread pain

Telephone-based therapy and exercise appear effective for reducing chronic widespread pain
Telephone-based therapy and exercise appear effective for reducing chronic widespread pain



Telephone-delivered cognitive behavioral therapy and an exercise program, both separately and combined, are associated with short-term positive outcomes for patients with chronic widespread pain, and may offer benefits for patients diagnosed with fibromyalgia, according to a report published Online First by Archives of Internal Medicine, one of the JAMA/Archives journals.

“In the United States, mean [average] per-patient costs (including pain and non-pain-related medication, physician consultations, tests and procedures, and emergency department visits) in the six months following a new diagnosis of fibromyalgia were $3,481,” the authors write as background information in the article. “There is a need to develop clinically effective and cost-effective, acceptable interventions at a primary care level that could potentially be available to a large number of patients.”

John McBeth, M.A., Ph.D., then of the Arthritis Research U.K. Epidemiology Unit, University of Manchester, England, now of the Arthritis Research U.K. Primary Care Centre, Keele University, Staffordshire, England, and colleagues conducted a randomized controlled trial to assess the effects of a telephone-based cognitive behavioral therapy, exercise, or a combined intervention among patients with chronic widespread pain.

The authors randomized 442 patients with chronic widespread pain to receive six months of telephone-delivered cognitive behavioral therapy (TCBT), graded exercise, combined intervention, or treatment as usual (control group). The primary outcome was self-rated score measuring how patients felt their health had changed since the period prior to entering the trial, which was measured using a 7-point scale on a questionnaire or telephone interview conducted by study personnel. A “positive outcome” was defined as feeling “much better” or “very much better.”

After six months (end of the intervention period), 8.1 percent of participants in the control group reported positive outcomes, compared with 29.9 percent of the TCBT group, 34.8 percent of the exercise group and 37.2 percent of the combined intervention group. Results were similar at the nine-month follow-up, with 8.3 percent of participants in the control group, 32.6 percent of the TCBT group, 24.2 percent of the exercise group and 37.1 percent of the combined intervention group reporting positive outcomes.

At the six and nine-month follow-ups, the combined intervention was associated with improvements in the 6-Item Short Form Health Questionnaire physical component score and a reduction in passive coping strategies.

“This trial demonstrates short- to medium-term improvements in patients with chronic widespread pain,” the authors conclude. “Whether improvements continue in the longer term should be established. These results provide encouragement that short-term improvement is possible in a substantial proportion of patients with chronic widespread pain.”

Mindfulness therapy reduces chronic pain in primary care

AMindfulness – What is it, why do it and is it worth it? Diary of a Mindfulness Course Part One


Results from a new clinical trial demonstrate that an eight-week mindfulness-based therapy—Mindfulness-Oriented Recovery Enhancement (MORE)—decreased opioid use and misuse while reducing chronic pain symptoms, with effects lasting as long as nine months. This is the first large-scale clinical trial to demonstrate that a psychological intervention can simultaneously reduce opioid misuse and chronic pain among people who were prescribed opioid pain relievers.

The study, published in the peer-reviewed journal JAMA Internal Medicine, followed 250 adults with chronic pain on long-term opioid therapy who met the criteria of misusing opioids. Most participants took oxycodone or hydrocodone, reported two or more painful conditions and met the clinical criteria for major depression. More than half of participants also had a diagnosable opioid use disorder.

Study participants were randomly assigned to either a standard supportive psychotherapy group, or a MORE group, both engaging in eight weekly two-hour group sessions, as well as 15 minutes of daily homework. The study treatment groups were delivered in doctor’s offices, in the same clinical care setting where patients received their opioid pain management. Researchers measured the participants’ opioid misuse behaviors; symptoms of pain; depression, anxiety and stress; and opioid dose through a nine-month follow-up. Opioid craving was measured at three random times a day, prompted by a text message sent to the participants’ smartphones. 

Nine months after the treatment period ended, 45% of participants in the MORE group were no longer misusing opioids, and 36% had cut their opioid use in half or greater. Patients in MORE had more than twice the odds of those in standard psychotherapy to stop misusing opioids by the end of the study. Additionally, participants in the MORE group reported clinically significant improvements in chronic pain symptoms, decreased opioid craving and reduced symptoms of depression to levels below the threshold for major depressive disorder. 

“MORE demonstrated one of the most powerful treatment effects I’ve seen,” said Eric Garland, lead author of the study, director of the Center on Mindfulness and Integrative Health Intervention Development at the University of Utah and the most prolific author of mindfulness research in the world.  “There’s nothing else out there that works this well in alleviating pain and curbing opioid misuse.”

“Remarkably, the effects of MORE seem to get stronger over time,” said Garland, who developed MORE and has been studying it for over a decade. “One possible explanation is that these individuals are integrating the skills they’ve learned through MORE into their everyday lives.” Garland also hypothesized that, based on previous research, the sustained benefits might be related to MORE’s ability to restructure the way the brain processes rewards, helping the participants’ brains shift from valuing drug-related rewards to valuing natural, healthy rewards like a beautiful sunset, the bloom of springtime flowers or the smile on the face of a loved one. 

MORE combines meditation, cognitive-behavioral therapy and principles from positive psychology into sequenced training in mindfulness, savoring and reappraisal skills. 

Participants are taught to break down the experience of pain or opioid craving into their sensory components, “zooming in” on what they are feeling and breaking it down into different sensations like heat, tightness or tingling. They are trained to notice how those experiences change over time, and to adopt the perspective of an observer. They are also taught to savor pleasant, healthful and life-affirming experiences, amplifying the sense of joy, reward and meaning that can come from positive, everyday events. Finally, participants are taught to reframe stressful events to find a sense of meaning in the face of adversity, to recognize what can be learned from difficult events and how dealing with those experiences might make a person stronger. 

Garland explained, “Rather than getting caught up in the pain or craving, we teach people how to step back and observe that experience from the perspective of an objective witness. When they can do that, people begin to recognize that who they truly are is bigger than any one thought or sensation. They are not defined by their experiences of pain or craving; their true nature is something more.”  

People experiencing both chronic pain and opioid misuse present a significant treatment challenge, since opioid use disorder has been shown to increase pain sensitivity, which in turn promotes further opioid misuse. By simultaneously reducing pain and opioid use, MORE may offer an effective, economical and lifesaving intervention to help halt the ongoing opioid crisis.